Literature DB >> 19393890

Corneal crosslinking: riboflavin concentration in corneal stroma exposed with and without epithelium.

Stefano Baiocchi1, Cosimo Mazzotta, Daniela Cerretani, Tomaso Caporossi, Aldo Caporossi.   

Abstract

PURPOSE: To evaluate intrastromal concentrations of riboflavin with and without epithelium to ensure the efficacy and safety of corneal crosslinking (CXL) by the standard and transepithelial procedures.
SETTING: Department of Ophthalmology and Department of Pharmacology G. Segre, Siena University, Siena, Italy.
METHODS: This study comprised keratoconic patients enrolled for penetrating keratoplasty (PKP) and warm-stored sclerocorneal rings unsuitable for transplantation. Half the PKP specimens were debrided, and half were left with the epithelium in situ. One of the latter and 1 debrided sample were not exposed to riboflavin (controls). Samples in both groups were soaked with 0.1% riboflavin-dextran 20% solution instilled every 2 minutes for 5, 15, and 30 minutes. Riboflavin concentrations were determined by high-performance liquid chromatography (HPLC).
RESULTS: The study evaluated 14 PKP specimens and 16 sclerocorneal rings. Control samples did not show a riboflavin emission peak. In exposed samples with epithelium, the mean riboflavin concentration was 91.88 ng/g after 5 minutes of exposure, 95.60 ng/g after 15 minutes, and 94.92 ng/g after 30 minutes. In the debrided samples, the mean riboflavin concentration was 14.42 microg/g, 20.92 microg/g, and 24.06 microg/g, respectively. No differences were seen between the in vivo samples and the ex vivo samples.
CONCLUSIONS: The HPLC quantitative study showed that stromal concentrations of riboflavin increased with exposure time only if the epithelium was removed. A theoretically safe and effective riboflavin concentration of 15 microg/g was obtained for ultraviolet A-induced CXL only after the epithelium was removed and after at least 10 minutes of riboflavin application every 2 minutes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19393890     DOI: 10.1016/j.jcrs.2009.01.009

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  51 in total

Review 1.  Corneal collagen crosslinking in keratoconus and other eye disease.

Authors:  Adel Alhayek; Pei-Rong Lu
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

2.  Standard, transepithelial and iontophoresis corneal cross-linking: clinical analysis of three surgical techniques.

Authors:  Settimio Rossi; Carmine Santamaria; Rosa Boccia; Luigi De Rosa; Francesco Maria D'Alterio; Francesca Simonelli; Giuseppe De Rosa
Journal:  Int Ophthalmol       Date:  2017-11-28       Impact factor: 2.031

3.  Pulsed vs continuous light accelerated corneal collagen crosslinking: in vivo qualitative investigation by confocal microscopy and corneal OCT.

Authors:  C Mazzotta; C Traversi; S Caragiuli; M Rechichi
Journal:  Eye (Lond)       Date:  2014-07-25       Impact factor: 3.775

4.  Corneal collagen crosslinking for keratoconus or corneal ectasia without epithelial debridement.

Authors:  N Hirji; E Sykakis; F C Lam; R Petrarca; S Hamada; D Lake
Journal:  Eye (Lond)       Date:  2015-03-20       Impact factor: 3.775

5.  Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis.

Authors:  Nacim Bouheraoua; Lea Jouve; Vincent Borderie; Laurent Laroche
Journal:  J Vis Exp       Date:  2015-11-12       Impact factor: 1.355

6.  Early epithelial complications of accelerated trans-epithelial corneal crosslinking in treatment of keratoconus: a case series.

Authors:  Sharon S W Chow; Tommy C Y Chan; Ian Y H Wong; Michelle C Y Fan; Jimmy S M Lai; Alex L K Ng
Journal:  Int Ophthalmol       Date:  2017-10-10       Impact factor: 2.031

7.  Systematic review and Meta-analysis comparing modified cross-linking and standard cross-linking for progressive keratoconus.

Authors:  Yang Liu; Yi Liu; Ying-Nan Zhang; Ai-Peng Li; Jing Zhang; Qing-Feng Liang; Ying Jie; Zhi-Qiang Pan
Journal:  Int J Ophthalmol       Date:  2017-09-18       Impact factor: 1.779

8.  Patient-specific computational modeling of keratoconus progression and differential responses to collagen cross-linking.

Authors:  Abhijit Sinha Roy; William J Dupps
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-25       Impact factor: 4.799

Review 9.  Current perspectives on corneal collagen crosslinking (CXL).

Authors:  Sandeepani K Subasinghe; Kelechi C Ogbuehi; George J Dias
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-06       Impact factor: 3.117

10.  BAC-EDTA transepithelial riboflavin-UVA crosslinking has greater biomechanical stiffening effect than standard epithelium-off in rabbit corneas.

Authors:  Andre A M Torricelli; Matthew R Ford; Vivek Singh; Marcony R Santhiago; William J Dupps; Steven E Wilson
Journal:  Exp Eye Res       Date:  2014-06-12       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.